Sawtooth Solutions LLC boosted its position in shares of IBM (NYSE:IBM) by 291.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,095 shares of the technology company’s stock after purchasing an additional 9,006 shares during the period. Sawtooth Solutions LLC’s holdings in IBM were worth $1,856,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently added to or reduced their stakes in the business. Farmers & Merchants Investments Inc. grew its holdings in shares of IBM by 5.5% in the 4th quarter. Farmers & Merchants Investments Inc. now owns 5,807 shares of the technology company’s stock valued at $891,000 after acquiring an additional 303 shares in the last quarter. Denali Advisors LLC grew its holdings in shares of IBM by 0.3% in the 4th quarter. Denali Advisors LLC now owns 90,214 shares of the technology company’s stock valued at $13,841,000 after acquiring an additional 309 shares in the last quarter. Trust Co grew its holdings in shares of IBM by 1.2% in the 3rd quarter. Trust Co now owns 27,673 shares of the technology company’s stock valued at $4,015,000 after acquiring an additional 316 shares in the last quarter. NewSquare Capital LLC grew its holdings in shares of IBM by 4.7% in the 4th quarter. NewSquare Capital LLC now owns 7,661 shares of the technology company’s stock valued at $1,175,000 after acquiring an additional 341 shares in the last quarter. Finally, Beacon Financial Group grew its holdings in shares of IBM by 5.0% in the 4th quarter. Beacon Financial Group now owns 7,261 shares of the technology company’s stock valued at $1,114,000 after acquiring an additional 344 shares in the last quarter. Hedge funds and other institutional investors own 56.85% of the company’s stock.
Shares of IBM stock opened at $144.30 on Tuesday. The company has a debt-to-equity ratio of 2.21, a current ratio of 1.37 and a quick ratio of 1.33. The company has a market cap of $132.32 billion, a price-to-earnings ratio of 10.46, a P/E/G ratio of 2.11 and a beta of 0.92. IBM has a 12-month low of $144.33 and a 12-month high of $145.12.
IBM (NYSE:IBM) last issued its quarterly earnings data on Tuesday, April 17th. The technology company reported $2.45 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.42 by $0.03. The firm had revenue of $19.07 billion during the quarter, compared to the consensus estimate of $18.80 billion. IBM had a net margin of 7.10% and a return on equity of 69.71%. The business’s revenue for the quarter was up 5.1% compared to the same quarter last year. During the same period last year, the business posted $2.35 earnings per share. sell-side analysts anticipate that IBM will post 13.83 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Saturday, June 9th. Stockholders of record on Thursday, May 10th will be given a $1.57 dividend. This represents a $6.28 dividend on an annualized basis and a dividend yield of 4.35%. This is an increase from IBM’s previous quarterly dividend of $1.50. The ex-dividend date is Wednesday, May 9th. IBM’s payout ratio is presently 45.51%.
In other news, insider Erich Clementi sold 13,000 shares of IBM stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $154.66, for a total value of $2,010,580.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Diane J. Gherson sold 5,000 shares of IBM stock in a transaction that occurred on Monday, February 26th. The shares were sold at an average price of $156.00, for a total transaction of $780,000.00. Following the completion of the sale, the insider now owns 20,581 shares of the company’s stock, valued at $3,210,636. The disclosure for this sale can be found here. 0.17% of the stock is currently owned by insiders.
Several equities analysts have recently weighed in on IBM shares. Barclays upgraded IBM from an “underweight” rating to an “overweight” rating and raised their price objective for the company from $133.00 to $192.00 in a report on Wednesday, January 17th. Wedbush restated a “neutral” rating and issued a $185.00 price objective (up previously from $155.00) on shares of IBM in a report on Thursday, January 18th. They noted that the move was a valuation call. Morgan Stanley raised their price objective on IBM to $198.00 and gave the company an “overweight” rating in a report on Friday, January 19th. Pivotal Research set a $180.00 price objective on IBM and gave the company a “buy” rating in a report on Thursday, January 18th. Finally, Bank of America reiterated a “buy” rating and set a $200.00 price target on shares of IBM in a report on Friday, January 19th. Seven analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and ten have given a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $166.90.
International Business Machines Corporation operates as an integrated technology and services company worldwide. Its Cognitive Solutions segment offers Watson, a cognitive computing platform that interacts in natural language, processes big data, and learns from interactions with people and computers.
Receive News & Ratings for IBM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IBM and related companies with MarketBeat.com's FREE daily email newsletter.